{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T14:06:28Z","timestamp":1785506788010,"version":"3.56.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"crossref","award":["THC-135235"],"award-info":[{"award-number":["THC-135235"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000038","name":"NSERC","doi-asserted-by":"crossref","award":["RGPIN-2018-04313"],"award-info":[{"award-number":["RGPIN-2018-04313"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000038","name":"NSERC","doi-asserted-by":"crossref","award":["RGPIN-2024-06629"],"award-info":[{"award-number":["RGPIN-2024-06629"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10067-026-08096-w","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T09:18:50Z","timestamp":1775639930000},"page":"3597-3607","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Risk and trends of severe infection in patients with antineutrophil cytoplasmic antibody\u2013associated vasculitides: a two-part population-based trajectory analysis"],"prefix":"10.1007","volume":"45","author":[{"given":"Kai","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Antonio","family":"Avi\u00f1a-Zubieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Dehghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Esdaile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3328-7135","authenticated-orcid":false,"given":"Hui","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"issue":"1","key":"8096_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F et al (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65(1):1\u201311","journal-title":"Arthritis Rheum"},{"issue":"6","key":"8096_CR2","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1136\/ard.2009.109389","volume":"69","author":"MA Little","year":"2010","unstructured":"Little MA, Nightingale P, Verburgh CA, Hauser T, De Groot K, Savage C et al (2010) Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis. Ann Rheum Dis 69(6):1036\u20131043","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"8096_CR3","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1136\/annrheumdis-2016-210942","volume":"76","author":"JA Tan","year":"2017","unstructured":"Tan JA, Dehghan N, Chen W, Xie H, Esdaile JM, Avina-Zubieta JA (2017) Mortality in ANCA-associated vasculitis: ameta-analysis of observational studies. Ann Rheum Dis 76(9):1566\u20131574","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"8096_CR4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s198-002-8341-z","volume":"13","author":"MM Boomsma","year":"2002","unstructured":"Boomsma MM, Stegeman CA, Kramer AB, Karsijns M, Piers DA, Tervaert JW (2002) Prevalence of reduced bone mineral density in patients with anti-neutrophil cytoplasmic antibody associated vasculitis and the role of immunosuppressive therapy: a cross-sectional study. Osteoporos Int 13(1):74\u201382","journal-title":"Osteoporos Int"},{"issue":"1","key":"8096_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/acr.23587","volume":"71","author":"JA Tan","year":"2019","unstructured":"Tan JA, Choi HK, Xie H, Sayre EC, Esdaile JM, Avi\u00f1a\u2010Zubieta JA (2019) All\u2010cause and cause\u2010specific mortality in patients with granulomatosis with polyangiitis: a population\u2010based study. Arthritis Care Res 71(1):155\u201363","journal-title":"Arthritis Care Res"},{"issue":"1","key":"8096_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-018-1102-3","volume":"19","author":"D Titeca-Beauport","year":"2018","unstructured":"Titeca-Beauport D, Francois A, Lobbedez T, Guerrot D, Launay D, Vrigneaud L et al (2018) Early predictors of one-year mortality in patients over 65 presenting with ANCA-associated renal vasculitis: a retrospective, multicentre study. BMC Nephrol 19(1):317","journal-title":"BMC Nephrol"},{"issue":"1","key":"8096_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S0022-3476(05)83482-1","volume":"122","author":"M Rottem","year":"1993","unstructured":"Rottem M, Fauci AS, Hallahan CW, Kerr GS, Lebovics R, Leavitt RY et al (1993) Wegener granulomatosis in children and adolescents: clinical presentation and outcome. J Pediatr 122(1):26\u201331","journal-title":"J Pediatr"},{"issue":"2","key":"8096_CR8","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1378\/chest.109.2.430","volume":"109","author":"SS Krafcik","year":"1996","unstructured":"Krafcik SS, Covin RB, Lynch JP 3rd, Sitrin RG (1996) Wegener\u2019s granulomatosis in the elderly. Chest 109(2):430\u2013437","journal-title":"Chest"},{"issue":"3","key":"8096_CR9","doi-asserted-by":"publisher","first-page":"416","DOI":"10.2215\/CJN.07300712","volume":"8","author":"R Goupil","year":"2013","unstructured":"Goupil R, Brachemi S, Nadeau-Fredette AC, D\u00e9ziel C, Troyanov Y, Lavergne V et al (2013) Lymphopenia and treatment-related infectious complications in ANCA-associated vasculitis. Clin J Am Soc Nephrol 8(3):416\u2013423","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl 1","key":"8096_CR10","doi-asserted-by":"publisher","first-page":"i171","DOI":"10.1093\/ndt\/gfv045","volume":"30 Suppl 1","author":"JG McGregor","year":"2015","unstructured":"McGregor JG, Negrete-Lopez R, Poulton CJ, Kidd JM, Katsanos SL, Goetz L et al (2015) Adverse events and infectious burden, microbes and temporal outline from immunosuppressive therapy in antineutrophil cytoplasmic antibody-associated vasculitis with native renal function. Nephrol Dial Transplant 30 Suppl 1(Suppl 1):i171-81","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"8096_CR11","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.3899\/jrheum.160909","volume":"44","author":"AJ Mohammad","year":"2017","unstructured":"Mohammad AJ, Segelmark M, Smith R, Englund M, Nilsson J, Westman K et al (2017) Severe infection in antineutrophil cytoplasmic antibody-associated vasculitis. J Rheumatol 44(10):1468\u201375","journal-title":"J Rheumatol"},{"issue":"3","key":"8096_CR12","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3899\/jrheum.190065","volume":"47","author":"E Garcia-Vives","year":"2020","unstructured":"Garcia-Vives E, Segarra-Medrano A, Martinez-Valle F, Agraz I, Solans-Laque R (2020) Prevalence and risk factors for major infections in patients with antineutrophil cytoplasmic antibody-associated vasculitis: influence on the disease outcome. J Rheumatol 47(3):407\u2013414","journal-title":"J Rheumatol"},{"issue":"10","key":"8096_CR13","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1093\/rheumatology\/keaa070","volume":"59","author":"SH Sarica","year":"2020","unstructured":"Sarica SH, Dhaun N, Sznajd J, Harvie J, McLaren J, McGeoch L et al (2020) Characterizing infection in anti-neutrophil cytoplasmic antibody-associated vasculitis: results from a longitudinal, matched-cohort data linkage study. Rheumatology (Oxford) 59(10):3014\u201322","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"8096_CR14","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1086\/514589","volume":"26","author":"P Pastor","year":"1998","unstructured":"Pastor P, Medley F, Murphy TV (1998) Invasive pneumococcal disease in Dallas county, Texas: results from population-based surveillance in 1995. Clin Infect Dis 26(3):590\u2013595","journal-title":"Clin Infect Dis"},{"issue":"5","key":"8096_CR15","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1136\/ard.2008.088302","volume":"68","author":"C Charlier","year":"2009","unstructured":"Charlier C, Henegar C, Launay O, Pagnoux C, Berezn\u00e9 A, Bienvenu B et al (2009) Risk factors for major infections in Wegener granulomatosis: analysis of 113 patients. Ann Rheum Dis 68(5):658\u201363","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"8096_CR16","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006083","volume":"96","author":"R Solans-Laqu\u00e9","year":"2017","unstructured":"Solans-Laqu\u00e9 R, Fraile G, Rodriguez-Carballeira M, Caminal L, Castillo MJ, Mart\u00ednez-Valle F et al (2017) Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides: Impact of the vasculitis type, ANCA specificity, and treatment on mortality and morbidity. Medicine (Baltimore) 96(8):e6083","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"8096_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-018-0933-2","volume":"19","author":"L Yang","year":"2018","unstructured":"Yang L, Xie H, Liu Z, Chen Y, Wang J, Zhang H et al (2018) Risk factors for infectious complications of ANCA-associated vasculitis: a cohort study. BMC Nephrol 19(1):138","journal-title":"BMC Nephrol"},{"issue":"1","key":"8096_CR18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13075-021-02452-8","volume":"23","author":"K Thomas","year":"2021","unstructured":"Thomas K, Argyriou E, Kapsala N, Panagiotopoulos A, Chalkia A, Hadziyannis E et al (2021) Serious infections in ANCA-associated vasculitides in the biologic era: real-life data from a multicenter cohort of 162 patients. Arthritis Res Ther 23(1):90","journal-title":"Arthritis Res Ther"},{"key":"8096_CR19","unstructured":"Annual Demographic Estimates (2015): Canada, provinces and territories. Statistics Canada (2015). https:\/\/www150.statcan.gc.ca\/."},{"key":"8096_CR20","unstructured":"British Columbia Ministry of Health[creator] (2017): Medical Services Plan (MSP) Payment Information File. Population Data BC [publisher]. Data Extract. MOH (2017). https:\/\/www.popdata.bc.ca\/data."},{"key":"8096_CR21","unstructured":"Canadian Institute for Health Information [creator] (2017): Discharge abstract database (hospital separations). Population Data BC [publisher]. Data Extract. MOH (2017). http:\/\/www.popdata.bc.ca\/data."},{"key":"8096_CR22","unstructured":"BC Cancer Agency Registry Data (2017). Population Data BC [publisher]. Data Extract. BC Cancer Agency (2017). http:\/\/www.popdata.bc.ca\/data."},{"key":"8096_CR23","unstructured":"BC Vital Statistics Agency [creator] (2017): Vital statistics deaths. Population Data BC [publisher]. Data Extract BC Vital Statistics Agency (2017).\u00a0http:\/\/www.popdata.bc.ca\/data."},{"key":"8096_CR24","unstructured":"BC Ministry of Health [creator] (2018): PharmaNet. BC Ministry of Health [publisher]. Data Extract. Data Stewardship Committee (2018). http:\/\/www.popdata.bc.ca\/data."},{"issue":"6","key":"8096_CR25","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1136\/annrheumdis-2016-209562","volume":"76","author":"D Lacaille","year":"2017","unstructured":"Lacaille D, Avina-Zubieta JA, Sayre EC, Abrahamowicz M (2017) Improvement in 5-year mortality in incident rheumatoid arthritis compared with the general population-closing the mortality gap. Ann Rheum Dis 76(6):1057\u20131063","journal-title":"Ann Rheum Dis"},{"issue":"24","key":"8096_CR26","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1001\/jama.2011.878","volume":"305","author":"DH Solomon","year":"2011","unstructured":"Solomon DH, Massarotti E, Garg R, Liu J, Canning C, Schneeweiss S (2011) Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis. JAMA 305(24):2525\u20132531","journal-title":"JAMA"},{"issue":"39","key":"8096_CR27","doi-asserted-by":"publisher","first-page":"E1070","DOI":"10.1503\/cmaj.190339","volume":"191","author":"C Yokose","year":"2019","unstructured":"Yokose C, Lu N, Xie H, Li L, Zheng Y, McCormick N et al (2019) Heart disease and the risk of allopurinol-associated severe cutaneous adverse reactions: a general population\u2013based cohort study. CMAJ 191(39):E1070\u2013E7","journal-title":"CMAJ"},{"key":"8096_CR28","doi-asserted-by":"publisher","unstructured":"Li L, Xie H, Lu N, Esdaile JM, Avina-Zubieta JA (2019) The impact of systemic lupus erythematosus on the risk of newly diagnosed hip fracture. A general population-based study. Arthritis Care Res (Hoboken). https:\/\/doi.org\/10.1002\/acr.24112","DOI":"10.1002\/acr.24112"},{"key":"8096_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab219","author":"K Zhao","year":"2021","unstructured":"Zhao K, Xie H, Li L, Esdaile JM, Avi\u00f1a-Zubieta JA (2021) Increased risk of severe infections and mortality in patients with newly diagnosed systemic lupus erythematosus: a population-based study. Rheumatology. https:\/\/doi.org\/10.1093\/rheumatology\/keab219","journal-title":"Rheumatology"},{"key":"8096_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab643","author":"VY Zhou","year":"2021","unstructured":"Zhou VY, Lacaille D, Lu N, Kopec J, Garbuz D, Qian Y et al (2021) Has the incidence of total joint arthroplasty in rheumatoid arthritis decreased in the era of biologics use? A population-based cohort study. Rheumatology (Oxford). https:\/\/doi.org\/10.1093\/rheumatology\/keab643","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"8096_CR31","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1002\/acr.24550","volume":"74","author":"MR Hoque","year":"2022","unstructured":"Hoque MR, Avi\u00f1a-Zubieta JA, De Vera MA, Qian Y, Esdaile JM, Xie H (2022) Impact of antimalarial adherence on mortality among patients with newly diagnosed systemic lupus erythematosus: a population-based cohort study. Arthritis Care Res (Hoboken) 74(7):1089\u20131097","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"8096_CR32","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/acr.25466","volume":"77","author":"CA Jones","year":"2025","unstructured":"Jones CA, Guy P, Xie H, Sayre EC, Zhao K, Lacaille D (2025) Incidence of and risk of mortality after hip fractures in rheumatoid arthritis relative to the general population. Arthritis Care Res (Hoboken) 77(5):604\u2013613","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9","key":"8096_CR33","first-page":"1249","volume":"27","author":"CF Bell","year":"2021","unstructured":"Bell CF, Blauer-Peterson C, Mao J (2021) Burden of illness and costs associated with eosinophilic granulomatosis with polyangiitis: evidence from a managed care database in the United States. J Manag Care Spec Pharm 27(9):1249\u20131259","journal-title":"J Manag Care Spec Pharm"},{"issue":"12","key":"8096_CR34","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1002\/pds.4116","volume":"25","author":"AG Sreih","year":"2016","unstructured":"Sreih AG, Annapureddy N, Springer J, Casey G, Byram K, Cruz A et al (2016) Development and validation of case-finding algorithms for the identification of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis in large healthcare administrative databases. Pharmacoepidemiol Drug Saf 25(12):1368\u20131374","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8","key":"8096_CR35","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/art.23913","volume":"59","author":"D Lacaille","year":"2008","unstructured":"Lacaille D, Guh DP, Abrahamowicz M, Anis AH, Esdaile JM (2008) Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis. Arthritis Care Res 59(8):1074\u20131081","journal-title":"Arthritis Care Res"},{"issue":"8","key":"8096_CR36","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/acr.21959","volume":"65","author":"C Barber","year":"2013","unstructured":"Barber C, Lacaille D, Fortin PR (2013) Systematic review of validation studies of the use of administrative data to identify serious infections. Arthritis Care Res (Hoboken) 65(8):1343\u20131357","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"10","key":"8096_CR37","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/0895-4356(93)90103-8","volume":"46","author":"PS Romano","year":"1993","unstructured":"Romano PS, Roos LL, Jollis JG (1993) Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol 46(10):1075\u20131079","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"8096_CR38","doi-asserted-by":"publisher","first-page":"5300","DOI":"10.1093\/rheumatology\/keab219","volume":"60","author":"K Zhao","year":"2021","unstructured":"Zhao K, Xie H, Li L, Esdaile JM, Avi\u00f1a-Zubieta JA (2021) Increased risk of severe infections and mortality in patients with newly diagnosed systemic lupus erythematosus: a population-based study. Rheumatology (Oxford) 60(11):5300\u20135309","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"8096_CR39","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/acr.24112","volume":"73","author":"L Li","year":"2021","unstructured":"Li L, Xie H, Lu N, Esdaile JM, Avina-Zubieta JA (2021) The impact of systemic lupus erythematosus on the risk of newly diagnosed hip fracture. A general population-based study. Arthritis Care Res (Hoboken) 73(2):259\u2013265","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"8096_CR40","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR (1972) Regression models and life-tables. J Roy Stat Soc: Ser B (Methodol) 34(2):187\u2013220","journal-title":"J Roy Stat Soc: Ser B (Methodol)"},{"issue":"3","key":"8096_CR41","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","volume":"81","author":"PM Grambsch","year":"1994","unstructured":"Grambsch PM, Therneau TM (1994) Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81(3):515\u2013526","journal-title":"Biometrika"},{"issue":"2","key":"8096_CR42","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3126\/nje.v7i2.17974","volume":"7","author":"SS Nitika Mishra","year":"2017","unstructured":"Nitika Mishra SS, Lohani P (2017) Lexis Expansion: a prerequisite for analyzing time changing variables in a cohort study. Nepal J Epidemiol 7(2):681\u20134","journal-title":"Nepal J Epidemiol"},{"issue":"2","key":"8096_CR43","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1136\/ard.2006.054593","volume":"66","author":"R Watts","year":"2007","unstructured":"Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W et al (2007) Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66(2):222\u2013227","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"8096_CR44","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1111\/j.0006-341X.2000.01030.x","volume":"56","author":"DB Hall","year":"2000","unstructured":"Hall DB (2000) Zero-inflated poisson and binomial regression with random effects: a case study. Biometrics 56(4):1030\u20131039","journal-title":"Biometrics"},{"key":"8096_CR45","unstructured":"British Columbia (1993) Information and privacy branch. Policy and procedures manual: the Freedom of Information and Protection of Privacy Act. British Columbia Ministry of Government Services, Victoria (BC), vol 2"},{"key":"8096_CR46","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev-pathol-011811-132453","volume":"8","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Hu P, Xiao H (2013) Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis. Annu Rev Pathol 8:139\u2013160","journal-title":"Annu Rev Pathol"},{"issue":"4","key":"8096_CR47","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.autrev.2012.08.007","volume":"12","author":"JU Holle","year":"2013","unstructured":"Holle JU, Gross WL (2013) Treatment of ANCA-associated vasculitides (AAV). Autoimmun Rev 12(4):483\u2013486","journal-title":"Autoimmun Rev"},{"issue":"Supplement_3","key":"8096_CR48","doi-asserted-by":"publisher","first-page":"iii60","DOI":"10.1093\/rheumatology\/keaa035","volume":"59","author":"I Neumann","year":"2020","unstructured":"Neumann I (2020) Immunosuppressive and glucocorticoid therapy for the treatment of ANCA-associated vasculitis. Rheumatology 59(Supplement_3):iii60\u2013iii67","journal-title":"Rheumatology"},{"issue":"9","key":"8096_CR49","first-page":"e5676","volume":"11","author":"M Harada","year":"2019","unstructured":"Harada M, Ishii W, Masubuchi T, Ichikawa T, Kobayashi M (2019) Relationship between immunosuppressive therapy and the development of infectious complications among patients with anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-center, retrospective observational study. Cureus 11(9):e5676-e","journal-title":"Cureus"},{"issue":"9","key":"8096_CR50","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","volume":"75","author":"M Yates","year":"2016","unstructured":"Yates M, Watts RA, Bajema IM, Cid MC, Crestani B, Hauser T et al (2016) EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis 75(9):1583\u201394","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"8096_CR51","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1136\/annrheumdis-2019-215882","volume":"79","author":"V Furer","year":"2020","unstructured":"Furer V, Rondaan C, Heijstek MW, Agmon-Levin N, van Assen S, Bijl M et al (2020) 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 79(1):39\u201352","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"8096_CR52","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.34067\/KID.0000502021","volume":"2","author":"L Floyd","year":"2021","unstructured":"Floyd L, Morris A, Joshi M, Dhaygude A (2021) Glucocorticoid therapy in ANCA vasculitis: using the glucocorticoid toxicity index as an outcome measure. Kidney360 2(6):1002\u201310","journal-title":"Kidney360"},{"issue":"1","key":"8096_CR53","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-021-00315-7","volume":"11","author":"H Koike","year":"2022","unstructured":"Koike H, Nishi R, Ohyama K, Morozumi S, Kawagashira Y, Furukawa S et al (2022) ANCA-associated vasculitic neuropathies: a review. Neurology and Therapy (1):18. https:\/\/doi.org\/10.1007\/s40120-021-00315-7","journal-title":"Neurology and Therapy"},{"issue":"7","key":"8096_CR54","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1056\/NEJMoa1803537","volume":"382","author":"M Walsh","year":"2020","unstructured":"Walsh M, Merkel PA, Peh C-A, Szpirt WM, Pu\u00e9chal X, Fujimoto S et al (2020) Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis. N Engl J Med 382(7):622\u201331","journal-title":"N Engl J Med"},{"issue":"10","key":"8096_CR55","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.2215\/CJN.02500317","volume":"12","author":"JC Jennette","year":"2017","unstructured":"Jennette JC, Nachman PH (2017) ANCA glomerulonephritis and vasculitis. Clin J Am Soc Nephrol 12(10):1680\u201391","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"8096_CR56","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1136\/annrheumdis-2021-221795","volume":"81","author":"JC Robson","year":"2022","unstructured":"Robson JC, Grayson PC, Ponte C, Suppiah R, Craven A, Judge A et al (2022) 2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis. Ann Rheum Dis 81(3):315\u201320","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"8096_CR57","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1093\/ije\/dyt127","volume":"42","author":"L Richiardi","year":"2013","unstructured":"Richiardi L, Bellocco R, Zugna D (2013) Mediation analysis in epidemiology: methods, interpretation and bias. Int J Epidemiol 42(5):1511\u20139","journal-title":"Int J Epidemiol"},{"key":"8096_CR58","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev.pu.03.050182.000333","volume":"3","author":"N Breslow","year":"1982","unstructured":"Breslow N (1982) Design and analysis of case-control studies. Annu Rev Public Health 3:29\u201354","journal-title":"Annu Rev Public Health"},{"issue":"11","key":"8096_CR59","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1002\/acr.23221","volume":"69","author":"T Beukelman","year":"2017","unstructured":"Beukelman T, Curtis JR, Saag KG (2017) Serious infections in childhood\u2010onset systemic lupus erythematosus: using administrative claims data to investigate disease outcomes. Arthritis Care Res 69(11):1617\u20139","journal-title":"Arthritis Care Res"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08096-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08096-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08096-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T06:01:46Z","timestamp":1780984906000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08096-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["8096"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08096-w","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,8]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}